20451 Seneca Meadows Parkway
We are a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Our first generation continuous glucose monitoring, or CGM, system is a reliable, long-term, implantable CGM system that we have designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 days, as compared to five to seven days for currently available CGM systems.
CEO: Timothy T. Goodnow, PhD
CFO: R. Don Elsey
Chief Medical Officer: E. Lynne Kelley, M.D., FACS